Rare copy number variations affecting the synaptic gene DMXL2 in neurodevelopmental disorders

Gregory A. Costain,S. Walker,B. Argiropoulos,D. Baribeau,Anne S. Bassett,Anne S. Bassett,E. Boot,K. Devriendt,B. Kellam,C. Marshall,Aparna Prasad,Moises A. Serrano,D. Stavropoulos,Hope Twede,J. Vermeesch,J. Vorstman,Stephen W. Scherer,Stephen W. Scherer

Published 2019 in Journal of Neurodevelopmental Disorders

ABSTRACT

Ultra-rare genetic variants, including non-recurrent copy number variations (CNVs) affecting important dosage-sensitive genes, are important contributors to the etiology of neurodevelopmental disorders (NDDs). Pairing family-based whole-genome sequencing (WGS) with detailed phenotype data can enable novel gene associations in NDDs. We performed WGS of six members from a three-generation family, where three individuals each had a spectrum of features suggestive of a NDD. CNVs and sequence-level variants were identified and further investigated in disease and control databases. We identified a novel 252-kb deletion at 15q21 that overlaps the synaptic gene DMXL2 and the gene GLDN. The microdeletion segregated in NDD-affected individuals. Additional rare inherited and de novo sequence-level variants were found that may also be involved, including a missense change in GRIK5. Multiple CNVs and loss-of-function sequence variants affecting DMXL2 were discovered in additional unrelated individuals with a range of NDDs. Disruption of DMXL2 may predispose to NDDs including autism spectrum disorder. The robust interpretation of private variants requires a multifaceted approach that incorporates multigenerational pedigrees and genome-wide and population-scale data.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-89 of 89 references · Page 1 of 1

CITED BY

Showing 1-13 of 13 citing papers · Page 1 of 1